Zinc-phosphate nanoparticles with reversibly attached TNF-α analogs: An interesting concept for potential use in active immunotherapy

Journal of Nanoparticle Research

Volumn 13, Issue 7, 2011, Pages 3019-3032

  Hribar, Gorazd ^a   Žnidaršič, Andrej ^a   Bele, Marjan ^a   Maver, Uroš ^a   Caserman, Simon ^a   Gaberšček, Miran ^a   Gaberc Porekar, Vladka ^a  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

Chronic inflammatory disease; Coordinative binding; Histidine residue; Nanomedicine; Protein nanoparticle; TNF analog; Zinc phosphate

Indexed keywords

CHRONIC INFLAMMATORY DISEASE; COORDINATIVE BINDING; HISTIDINE RESIDUES; NANOMEDICINES; ZINC-PHOSPHATE;

AGGLOMERATION; AMINO ACIDS; DISEASES; MEDICAL NANOTECHNOLOGY; PRECIPITATION (CHEMICAL); PROTEINS; ZINC;

NANOPARTICLES;

DACTINOMYCIN; EPITOPE; HISTIDINE; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; ZINC PHOSPHATE;

ACTIVE IMMUNIZATION; ANIMAL CELL; ARTICLE; CHEMICAL BOND; DRUG BINDING; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 80052625703     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-010-0199-5     Document Type: Article

References (28)

1. Augustsson J, Jonsdottir T, Klareskog L, van Vollenhoven RF (2006) Infliximab in the treatment of rheumatoid arthritis. Aging Health 2(1):19-33
2. Bele M, Hribar G, Campelj S et al (2008) Zinc-decorated silica-coated magnetic nanoparticles for protein binding and controlled release. J Chromatogr B 867(1):160-164
3. Boehncke WH (2007) Etanercept: A soluble TNF-A receptor in the treatment of psoriasis. Therapy 4(5):665-672
4. Chaga GS (2001) Twenty-five years of immobilized metal ion affinity chromatography: Past, present and future. J Biochem Biophys Methods 49(1-3):313-334 (Pubitemid 33022557)
5. Chikh GG, Li WM, Schutze-Redelmeier MP, Meunier JC, Bally MB (2002) Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metalion-chelating lipids. Biochim Biophys Acta 1567(1-2): 204-212 (Pubitemid 35454062)
6. Dalum I, Butler DM, Jensen MR et al (1999) Therapeutic antibodies elicited by immunization against TNF-alpha. Nat Biotechnol 17(7):666-669 (Pubitemid 29316144)
7. Delavallee L, Assier E, Denys A, Falgarone G, Zagury JF, Muller S, Bessis N, Boissier MC (2008) Vaccination with cytokines in autoimmune diseases. Ann Med 40(5): 343-351 (Pubitemid 351882892)
8. Fonda I, Kenig M, Gaberc-Porekar V, Pristovsek P, Menart V (2002) Attachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties. Sci World J 2:1312-1325
9. Frenzel A, Bergemann C, Kohl G, Reinard T (2003) Novel purification system for 6xHis-tagged proteins by magnetic affinity separation. J Chromatogr B 793(2):325-329 (Pubitemid 37271972)
10. Gaberc-Porekar V, Menart V (2001) Perspectives of immobilized-metal affinity chromatography. J Biochem Biophys Methods 49(1-3):335-360 (Pubitemid 33022558)
11. Gaberc-Porekar V, Menart V (2005) Potential for using histidine tags in purification of proteins at large scale. Chem Eng Technol 28(11):1306-1314 (Pubitemid 41694143)
12. Gaberc-Porekar V, Menart V, Jevsevar S, Vidensek A, Stalc A (1999) Histidines in affinity tags and surface clusters for immobilized metal-ion affinity chromatography of trimeric tumor necrosis factor alpha. J Chromatogr A 852(1):117-128 (Pubitemid 29347063)
13. Herschke L, Lieberwirth I, Wegner G (2006a) Zinc phosphate as versatile material for potential biomedical applications Part II. J Mater Sci 17(1):95-104 (Pubitemid 43042232)
14. Herschke L, Rottstegge J, Lieberwirth I, Wegner G (2006b) Zinc phosphate as versatile material for potential biomedical applications part 1. J Mater Sci 17(1):81-94 (Pubitemid 43042231)
15. Hillaireau H, Couvreur P (2009) Nanocarriers' entry into the cell: Relevance to drug delivery. Cell Mol Life Sci 66(17):2873-2896
16. Holtmann MH, Neurath MF (2004) Differential TNF-signaling in chronic inflammatory disorders. Curr Mol Med 4(4): 439-444 (Pubitemid 38787012)
17. Lee SJ, Kavanaugh A (2005) Adalimumab for the treatment of rheumatoid arthritis. Therapy 2(1):13-21 (Pubitemid 40207808)
18. Mease JP (2009) Certolizumab pegol for rheumatoid arthritis: Effective in combination with methotrexate or as monotherapy. Int J Clin Rheumatol 4(3):253-266
19. Patel JD, O'Carra R, Jones J, Woodward JG, Mumper RJ (2007) Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens. Pharm Res 24(2):343-352 (Pubitemid 46072193)
20. Spohn G, Guler R, Johansen P et al (2007) A virus-like particle-based vaccine selectively targeting soluble TNFalpha protects from arthritis without inducing reactivation of latent tuberculosis. J Immunol 178(11):7450-7457 (Pubitemid 46847473)
21. Sprules T, Green N, Featherstone M, Gehring K (1998) Nickelinduced oligomerization of proteins containing 10-histidine tags. Biotechniques 25(1):20-22 (Pubitemid 28328370)
22. Steed PM, Tansey MG, Zalevsky J, Zhukovsky EA, Desjarlais JR, Szymkowski DE, Abbott C, Carmichael D, Chan C, Cherry L et al (2003) Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Science 301(5641):1895-1898 (Pubitemid 37221393)
23. Tabata Y, Noda Y, Matsui Y, Ikada Y (1999) Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination. J Control Release 59(2):187-196 (Pubitemid 29199924)
24. Tian ZM, Wan MX, Wang B, Wang SP, Wu XM, Ruan YS (2003) Effects of ultrasound on the structure and function of tumor necrosis factor-alpha. Ultrasound Med Biol 29(9):1331-1339 (Pubitemid 37211333)
25. Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10(1):45-65 (Pubitemid 36511832)
26. Wang TW, Xu Q, Wu Y, Zeng AJ, Li MJ, Gao HX (2009) Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system. Carbohydr Res 344(7):908-914
27. Watanabe M, Uchida K, Nakagaki K et al (2007) Anti-cytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett 581(10):2017-2021 (Pubitemid 46670127)
28. Zuany-Amorim C, Manlius C, Dalum I et al (2004) Induction of TNF-alpha autoantibody production by AutoVac TNF106: A novel therapeutic approach for the treatment of allergic diseases. Int Arch Allergy Immunol 133(2): 154-163 (Pubitemid 38314647)